Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Boots says
beta-cell failure in diabetes and preservation by clinical treatment
November 2023
Novo Nordisk finished January-September 2025 with DKK 95.264 billion ($14.907 billion) for semaglutide in adult type 2 diabetes (marketed as Ozempic ), up only 10% from DKK 86.489 billion ($13.533 billion) in January-September 2024
For context, brand-name GLP-1 injections like Wegovy or Zepbound can cost $1,000 or more per month without insurance
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
